Status:
COMPLETED
Efficacy of Dexpanthenol in Thermic Erythema
Lead Sponsor:
Bayer
Conditions:
Erythema
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The study focuses to prove the equivalent efficacy of two different Dexpanthenol formulations.
Eligibility Criteria
Inclusion
- Healthy subjects
- Phototype: I to IV according to Fitzpatrick scale
Exclusion
- Pregnant or nursing women
- Subjects registered as being in exclusion period in the French Health Minister file of subjects
- Subjects with known allergy to cosmetics, skin care products, or topical drugs, a sensitivity related to any component of any formulations being tested
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00839462
Start Date
September 1 2007
End Date
September 1 2007
Last Update
October 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Villeurbanne, France, 69503